Valeria Grünebaum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Valeria Grünebaum has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Christian Graeff
GSI Helmholtzzentrum fūr Schwerionenforschung, Darmstadt, Germany
1 shared publication - Claudia Fournier
Department of Biophysics GSI Helmholtz Centre for Heavy Ion Research Darmstadt Germany
1 shared publication D. Thomas
Department of Cardiology, University Hospital Heidelberg, Heidelberg, Germany
1 shared publicationDouglas L. Packer
Mayo Clinic/St. Marys Hospital, Rochester, MN, USA
1 shared publication- Felicitas Rapp
Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
1 shared publication - Helge Immo Lehmann
Department of Internal Medicine Division of Cardiovascular Medicine, University of Utah School of Medicine Salt Lake City Utah USA
1 shared publication
Latest Publications
- Open Access
- 21 March 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-13
Biological Cardiac Tissue Effects of High-Energy Heavy Ions – Investigation for Myocardial Ablation
Noninvasive X-ray stereotactic treatment is considered a promising alternative to catheter ablation in patients affected by severe heart arrhythmia. High-energy heavy ions can deliver high radiation doses in small targets with reduced damage to the normal tissue compared to conventional X-rays. For this reason, charged particle therapy, widely used in oncology, can be a powerful tool for radiosurgery in cardiac diseases. We have recently performed a feasibility study in a swine model using high doses of high-energy C-ions to target specific cardiac structures. Interruption of cardiac conduction was observed in some animals. Here we report the biological effects measured in the pig heart tissue of the same animals six months after the treatment. Immunohistological analysis of the target tissue showed (1.) long-lasting vascular damage, i.e. persistent hemorrhage, loss of microvessels, and occurrence of siderophages, (2.) fibrosis and (3.) loss of polarity of targeted cardiomyocytes and wavy fibers with vacuolization. We conclude that the observed physiological changes in heart function are produced by radiation-induced fibrosis and cardiomyocyte functional inactivation. No effects were observed in the normal tissue traversed by the particle beam, suggesting that charged particles have the potential to produce ablation of specific heart targets with minimal side effects.
- 21 March 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-13
Open AccessBiological Cardiac Tissue Effects of High-Energy Heavy Ions – Investigation for Myocardial Ablation
Noninvasive X-ray stereotactic treatment is considered a promising alternative to catheter ablation in patients affected by severe heart arrhythmia. High-energy heavy ions can deliver high radiation doses in small targets with reduced damage to the normal tissue compared to conventional X-rays. For this reason, charged particle therapy, widely used in oncology, can be a powerful tool for radiosurgery in cardiac diseases. We have recently performed a feasibility study in a swine model using high doses of high-energy C-ions to target specific cardiac structures. Interruption of cardiac conduction was observed in some animals. Here we report the biological effects measured in the pig heart tissue of the same animals six months after the treatment. Immunohistological analysis of the target tissue showed (1.) long-lasting vascular damage, i.e. persistent hemorrhage, loss of microvessels, and occurrence of siderophages, (2.) fibrosis and (3.) loss of polarity of targeted cardiomyocytes and wavy fibers with vacuolization. We conclude that the observed physiological changes in heart function are produced by radiation-induced fibrosis and cardiomyocyte functional inactivation. No effects were observed in the normal tissue traversed by the particle beam, suggesting that charged particles have the potential to produce ablation of specific heart targets with minimal side effects.